E. Mahalatchimy, V. Rial-sebbag, A. Tournay, and . Faulkner, The Legal Landscape for Advanced Therapies: Material and Institutional Implementation of European Union Rules in France and the United Kingdom, Journal of Law and Society, vol.39, issue.1, pp.131-149, 2012.
DOI : 10.1111/j.1467-6478.2012.00574.x
URL : https://hal.archives-ouvertes.fr/hal-01560611

E. Rial-sebbag and F. Taboulet, Encadrement juridique des essais cliniques de thérapies innovantes : état de la question en droit français, Le Médicament : Conception, Production et Consommation : Perspectives Interdisciplinaires pour un Avenir Commun, pp.309-318, 2005.

E. Bioy, L'évolution de la recherche sur l'embryon, une question de principes, Les Petites affiches, pp.251-255, 2013.

L. Davies and A. Denoon, Brüstle decision is unhelpful, but not catastrophic, Cell Stem Cell, issue.9, pp.500-501, 2011.

. Hauser, Brevetabilité des inventions sur l'embryon (suite et fin), RTD civ, pp.85-87, 2012.

. Hennette-vauchez, Biomedicine and EU law : unlikely encounters ?, Legal Issues of Economic Integration, vol.38, issue.1, pp.5-31, 2011.
URL : https://hal.archives-ouvertes.fr/hal-01175684

A. Favale and . Plomer, Fundamental disjunctions in the EU legal order on human tissue, cells & advanced regenerative therapies 89-111. 66 WHO guiding principles on human cell, tissue and organ transplantation, Maastricht Journal of European and Comparative Law, vol.16, issue.1, 2009.